A Prospective Observational Registry of H.P. Acthar Gel for the Treatment of Multiple Sclerosis Relapse
Phase of Trial: Phase IV
Latest Information Update: 09 Aug 2017
At a glance
- Drugs Corticotropin (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Mallinckrodt plc
- 25 May 2017 Preliminary demographic data and safety results published in a Mallinckrodt plc media release.
- 25 May 2017 according to a Mallinckrodt plc media release, preliminary demographic data from the study will be presented at the 2017 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC).
- 22 Dec 2015 New trial record